Chinese Journal of Pharmacovigilance ›› 2022, Vol. 19 ›› Issue (5): 572-573.
DOI: 10.19803/j.1672-8629.2022.05.22

Previous Articles     Next Articles

Pharmaceutical care for a patient with urinary tract infection and drug fever

YANG Baochun, SUN Xin, YANG Xin, WU Lin, WANG Liping*   

  1. Department of Pharmacy, Wuxi Second Hospital, Nanjing Medical University, Wuxi Jiangsu 214000, China
  • Received:2020-08-15 Online:2022-05-15 Published:2022-05-18

Abstract: Objective To explore the effect of monitoring of drug use by clinical pharmacists for a patient with urinary tract infection and to advance physicians' and pharmacists' understanding of drug fever. Methods A clinical pharmacist participated in the analysis and intervention of a suspected cefdiazine-induced fever patient. Results Based on the mechanism, clinical characteristics of drug fever, clinical symptoms, laboratory test results and drug use of the patient, the clinical pharmacist suspected that the fever might have been caused by cefdiazine and suggested that cefdiazine be discontinued. The clinician took the advice so that the patient's temperature gradually returned to normal. Conclusion Active participation in drug monitoring by clinical pharmacists will help to detect adverse drug reactions as soon as possible so as to prevent irrational use of drugs.

Key words: clinical pharmacists, drug fever, cefodizime, adverse drug reaction

CLC Number: